Volume | 928,068 |
|
|||||
News | - | ||||||
Day High | 0.175 | Low High |
|||||
Day Low | 0.1532 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Onconetix Inc | ONCO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.17 | 0.1532 | 0.175 | 0.1624 | 0.1781 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,003 | 928,068 | $ 0.1611514 | $ 149,559 | - | 0.1001 - 0.535 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:43 | 16 | $ 0.165 | USD |
Onconetix Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.36M | 18.66M | - | 58k | -37.41M | -2.01 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Onconetix News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONCO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.232 | 0.2354 | 0.1532 | 0.1972932 | 2,397,312 | -0.0738 | -31.81% |
1 Month | 0.116 | 0.535 | 0.1014 | 0.2504208 | 12,132,219 | 0.0422 | 36.38% |
3 Months | 0.168 | 0.535 | 0.1001 | 0.2443234 | 4,217,394 | -0.0098 | -5.83% |
6 Months | 0.20 | 0.535 | 0.1001 | 0.27448 | 4,230,875 | -0.0418 | -20.90% |
1 Year | 0.20 | 0.535 | 0.1001 | 0.27448 | 4,230,875 | -0.0418 | -20.90% |
3 Years | 0.20 | 0.535 | 0.1001 | 0.27448 | 4,230,875 | -0.0418 | -20.90% |
5 Years | 0.20 | 0.535 | 0.1001 | 0.27448 | 4,230,875 | -0.0418 | -20.90% |
Onconetix Description
Blue Water Vaccines Inc is a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases. Its versatile vaccine platform has molecular properties that enable delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. |